Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 21, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Following the publication of data suggesting that EBV is a leading cause of MS, the director of the Ochsner MS Center and an investigator in an EBV-specific therapy clinical trial offered her reaction to the data.
Episode 8 of this NeurologyLive® Peer Exchange™, "Unmet Needs in Treating Insomnia," experts Michael J. Thorpy, MD, ChB; Karl Doghramji, MD; Erinn E. Beagin, MD; Nathaniel Fletcher Watson, MD; and Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE offer perspectives on the benefits of and limitations to cognitive behavioral therapy for insomnia.
The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided an inside look at the ways MR fingerprinting can provide real-time clinical benefit for physicians and patient care in epilepsy.
The professor of neurology at NYU Langone Grossman School of Medicine discussed future research for neurological complications in patients hospitalized with COVID-19 infection, following the publication of a study evaluating neurological complications in 251 hospitalized patients.
A panel of expert neurologists, including Rebecca Erwin Wells, MD, MPH; Andrew C. Charles, MD; Stephanie J. Nahas, MD, MSEd, FAHS, FAAN; Christopher Gottschalk, MD, FAHS; and Jessica Ailani, MD shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to in episode 17 of this NeurologyLive® Peer Exchange™, "The Changing Landscape of Preventive Treatment of Migraine."
Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.